• US Stocks
  • Bristol-Myers Squibb Co.
Bristol-Myers Squibb Co.

Bristol-Myers Squibb Co.

BMY
HealthcareLarge Cap 
  • $ 56.28

    Stock Price

  • $ 0.02(0.04%)

    Last Change

About the company

Bristol-Myers Squibb Co.

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, and distributes biopharmaceutical products worldwide. The company offers chemically-synthesized drug and biologic in various therapeutic areas, such as oncology; cardiovascular; immunoscience; and virology comprising human immunodeficiency virus infection (HIV). Its products include Empliciti, a humanized monoclonal antibody to treat multiple myeloma; Opdivo, a human monoclonal antibody to treat renal cell carcinoma, non-small cell lung cancer, classical Hodgkin lymphoma, gastric cancer, melanoma, metastatic urothelial carcinoma, and squamous cell carcinoma of the head and neck; Erbitux, an IgG1 monoclonal antibody that blocks the epidermal growth factor receptor; Sprycel, a tyrosine kinase inhibitor for the treatment of adults with Philadelphia chromosome-positive chronic myeloid leukemia; and Yervoy, a monoclonal antibody for metastatic melanoma. The company's products also comprise Eliquis, an oral factor Xa inhibitor targeted at stroke prevention in atrial fibrillation; Baraclude to treat chronic hepatitis B virus; Daklinza and Sunvepra to treat hepatitis C virus (HCV); Reyataz and Sustiva to treat HIV; Abilify, an antipsychotic agent for adults with schizophrenia, bipolar mania disorder, and depressive disorder; Beclabuvir, a non-nucleoside NS5B inhibitor for the treatment of HCV; and Orencia to treat rheumatoid arthritis. It has collaborations with Portola Pharmaceuticals, Inc. to develop and commercialize andexanet alfa, an investigational agent; Apexigen, Inc. to evaluate Opdivo in combination with APX005M in patients with solid tumors; and license agreement with Nitto Denko Corporation to develop and commercialize siRNA molecules targeted at HSP47 in vitamin A. The company was formerly known as Bristol-Myers Company and changed its name to Bristol-Myers Squibb Company in 1989. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York.
View More
    Total Revenue
    $ 11.218 B
    Cost of Revenue
    $ 2.353 B
    Gross Profit
    $ 8.865 B
    Operating Income
    $ 2.099 B
Scripbox Recommended US Equity Funds
Want to get exposure to US Equity with the ease of Mutual Funds?Learn more

Price chart

$ 56.53

1D High

$ 55.91

1D Low

$ 0.02 (0.04%)

1D Change

Last updated on 

Previous Close
$ 56.26
Open Price
$ 56.37
52 Week High
$ 78.63
52 Week Low
$ 55.70
PE Ratio
15.01
Volume
2,227,189
Avg. Volume
10,983,957
Market Cap
$ 117.575 B
peers

Peers

Stock NameStock Price52 Week High52 Week LowCapital
AstraZeneca PLC
AstraZeneca PLC
$ 66.57$ 71.09$ 51.90Large Cap
$ 94.04$ 105.61$ 78.81Large Cap
$ 98.46$ 122.66$ 92.83Large Cap
$ 236.76$ 292.06$ 219.83Large Cap
$ 143.12$ 162.75$ 128.24Large Cap
$ 155.56$ 181.77$ 151.23Large Cap
$ 103.35$ 118.05$ 94.42Large Cap
$ 48.79$ 56.20$ 36.91Large Cap
$ 32.34$ 53.25$ 31.77Large Cap
$ 745.95$ 800.78$ 366.69Large Cap
peers

Frequently Asked Questions

What is the price of Bristol-Myers Squibb Co. share today in India?

Today, on 19th Apr 2024, the price of Bristol-Myers Squibb Co. Shares in India is $ 56.28.

What was the highest Bristol-Myers Squibb Co. share stock price?

The highest Bristol-Myers Squibb Co. stock price was $ 78.63 till 19th Apr 2024 within the past 52 weeks.

What is the lowest price of BMY shares?

The lowest BMY stock price was $ 55.7 on 19th Apr 2024 within the past 52 weeks.

How to buy BMY shares in India?

You can buy BMY shares in India through Scripbox in just 4 simple steps. The process is simple, seamless, and paperless.
  • Create an account and submit KYC documents
  • On successful KYC, transfer amount required for investment
  • Invest in US stocks
  • Track and manage investments through Scripbox dashboard

Is Bristol-Myers Squibb Co. shares Listed on NSE or BSE?

No, BMY shares are not listed on NSE or BSE. Bristol-Myers Squibb Co. is listed on the NASDAQ stock exchange.

Can I buy Bristol-Myers Squibb Co. shares in India?

Yes, you can buy Bristol-Myers Squibb Co. shares in India by simply opening an account with Scripbox.

Can I buy fractional shares of Bristol-Myers Squibb Co.?

Yes, you can buy fractional shares of Bristol-Myers Squibb Co. with Scripbox.

What is the P/E ratio for Bristol-Myers Squibb Co. shares?

As on 19th Apr 2024, the P/E ratio for Bristol-Myers Squibb Co. shares is 15.01.

What is the traded volume of Bristol-Myers Squibb Co. shares?

As on 19th Apr 2024, the traded volume for Bristol-Myers Squibb Co. shares is 2.227 M.

What is the market capitalization of Bristol-Myers Squibb Co. shares?

Bristol-Myers Squibb Co. shares has a market capitalization of $ 117.575 B.